Dr. Sandra Shotwell is an experienced biotech entrepreneur, with a passion for global health. She is cofounder and CEO of DesignMedix Inc and cofounder and board chair for Elex Biotech Inc, companies that develop small molecule therapeutics for infectious disease and heart disease, respectively. DesignMedix’s lead drug candidate designed to overcome drug resistance in malaria is in Phase I clinical trails at Duke Clinical Research Institute, sponsored by the NIH National Institute of Allergy and Infectious Disease.
Arena’s business-to-business events offer a myriad of opportunities for sponsors and exhibitors to drive their businesses forward.
Our sponsorship packages help companies educate ther target market on key industry issues and spread brand awareness throughout the
If you want to discuss how we can help you generate leads and add-value to your corporate and brand image please contact:
+44 (0)20 7936 6948